ATE244279T1 - Verfahren zur synthese von phthalocyaninverbindungen - Google Patents

Verfahren zur synthese von phthalocyaninverbindungen

Info

Publication number
ATE244279T1
ATE244279T1 AT97945416T AT97945416T ATE244279T1 AT E244279 T1 ATE244279 T1 AT E244279T1 AT 97945416 T AT97945416 T AT 97945416T AT 97945416 T AT97945416 T AT 97945416T AT E244279 T1 ATE244279 T1 AT E244279T1
Authority
AT
Austria
Prior art keywords
ligand
displacing
phthalocyanine
cl3ccoo
central silicon
Prior art date
Application number
AT97945416T
Other languages
English (en)
Inventor
Ying-Syi Li
Malcolm E Kenney
Original Assignee
Univ Cleveland Hospitals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cleveland Hospitals filed Critical Univ Cleveland Hospitals
Application granted granted Critical
Publication of ATE244279T1 publication Critical patent/ATE244279T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/30—Metal-free phthalocyanines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00—Porphines; Azaporphines
    • C09B47/04—Phthalocyanines abbreviation: Pc
    • C09B47/08—Preparation from other phthalocyanine compounds, e.g. cobaltphthalocyanineamine complex

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT97945416T 1996-10-01 1997-09-30 Verfahren zur synthese von phthalocyaninverbindungen ATE244279T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/724,347 US5763602A (en) 1996-10-01 1996-10-01 Methods of syntheses of phthalocyanine compounds
PCT/US1997/017690 WO1998014521A1 (en) 1996-10-01 1997-09-30 Novel methods of syntheses of phthalocyanine compounds

Publications (1)

Publication Number Publication Date
ATE244279T1 true ATE244279T1 (de) 2003-07-15

Family

ID=24910068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97945416T ATE244279T1 (de) 1996-10-01 1997-09-30 Verfahren zur synthese von phthalocyaninverbindungen

Country Status (9)

Country Link
US (1) US5763602A (de)
EP (1) EP1023399B1 (de)
JP (1) JP2001506584A (de)
KR (1) KR20000036186A (de)
AT (1) ATE244279T1 (de)
AU (1) AU4662697A (de)
CA (1) CA2267389A1 (de)
DE (1) DE69723322T2 (de)
WO (1) WO1998014521A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6322980B1 (en) * 1999-04-30 2001-11-27 Aclara Biosciences, Inc. Single nucleotide detection using degradation of a fluorescent sequence
US7160735B2 (en) * 2000-04-28 2007-01-09 Monogram Biosciences, Inc. Tagged microparticle compositions and methods
US20030207300A1 (en) * 2000-04-28 2003-11-06 Matray Tracy J. Multiplex analytical platform using molecular tags
US7537938B2 (en) * 2000-04-28 2009-05-26 Monogram Biosciences, Inc. Biomarker detection in circulating cells
US7771929B2 (en) * 2000-04-28 2010-08-10 Monogram Biosciences, Inc. Tag library compounds, compositions, kits and methods of use
CA2445053A1 (en) 2001-05-21 2002-11-28 Aclara Biosciences, Inc. Methods and compositions for analyzing proteins
US7041459B2 (en) 2001-05-21 2006-05-09 Monogram Biosciences, Inc. Analyzing phosphorylated proteins
WO2002096913A1 (en) * 2001-05-25 2002-12-05 Gentian As Substituted di(hydroxy/alkoxy)silicon phthalocyanines and their uses
WO2002097112A2 (en) * 2001-05-26 2002-12-05 Aclara Biosciences, Inc. Catalytic amplification of multiplexed assay signals
US20040229380A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB heterodimers as biomarkers
JP4443407B2 (ja) 2002-07-25 2010-03-31 アクララ バイオサイエンシーズ， インコーポレイテッド レセプターオリゴマー形成の検出
US20040091850A1 (en) * 2002-11-08 2004-05-13 Travis Boone Single cell analysis of membrane molecules
US7402398B2 (en) * 2003-07-17 2008-07-22 Monogram Biosciences, Inc. Measuring receptor homodimerization
EP1673399B1 (de) * 2003-08-11 2017-04-05 Monogram BioSciences, Inc. Nachweis und erstellung des profils eines molekularen komplexes
CA2543830A1 (en) * 2003-10-27 2005-05-19 Monogram Biosciences, Inc. Detecting human anti-therapeutic antibodies
US7939267B2 (en) * 2004-11-04 2011-05-10 Laboratory Corporation Of America Holdings Detection of activation of endothelial cells as surrogate marker for angiogenesis
WO2008098100A2 (en) * 2007-02-07 2008-08-14 Perscitus Biosciences, Llc Detection of molecule proximity
EP2235536A4 (de) * 2007-12-20 2011-05-04 Lab Corp America Holdings Her-2-diagnoseverfahren
ES2637411T3 (es) 2008-12-01 2017-10-13 Laboratory Corporation Of America Holdings Métodos y ensayos para medir p95 Y/O p95 en una muestra y anticuerpos específicos para p95
US20120295259A1 (en) 2011-05-19 2012-11-22 Laboratory Corporation Of America Holdings Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients
EP2387711B1 (de) 2009-01-15 2015-04-22 Laboratory Corporation of America Holdings Verfahren zur bestimmung von patientenreaktionen durch her-3-messung
EP2398868B1 (de) 2009-02-20 2016-06-15 Perkinelmer Biosignal, Inc. Multiplex-assayverfahren und zusammensetzungen
US8440641B2 (en) * 2009-03-20 2013-05-14 Case Western Reserve University Phthalocyanine salt formulations
WO2013020067A1 (en) 2011-08-03 2013-02-07 Sun Chemical Corporation Phthalocyanine synthesis
KR101471613B1 (ko) * 2013-02-07 2014-12-12 광주과학기술원 고분자 태양전지 및 이의 제조방법
US20160041171A1 (en) 2013-04-05 2016-02-11 Laboratory Corporation Of America Holdings Systems and methods for facilitating diagnosis, prognosis and treatment of cancer based on detection of her3 activation
WO2017161030A1 (en) 2016-03-15 2017-09-21 Laboratory Corporation Of America Holdings Methods of assessing protein interactions between cells
ES2883182T3 (es) 2016-07-06 2021-12-07 Prothena Biosciences Ltd Ensayo para la detección de alfa-sinucleína total y fosforilada en S129
WO2018106945A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
JP2020502126A (ja) 2016-12-14 2020-01-23 プロジェニティ， インコーポレイテッド 消化管疾病のｊａｋ阻害薬による治療
EP3554541B1 (de) 2016-12-14 2023-06-07 Biora Therapeutics, Inc. Behandlung einer erkrankung des gastrointestinaltraktes mit einem chemokin/chemokin-rezeptor-inhibitor
CN117045784A (zh) 2016-12-14 2023-11-14 比奥拉治疗股份有限公司 使用利用可摄入装置释放的il-12/il-23抑制剂治疗胃肠道疾病
US11426566B2 (en) 2016-12-14 2022-08-30 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with a TLR modulator
JP2020513280A (ja) 2016-12-14 2020-05-14 プロジェニティ， インコーポレイテッド 消化管疾病の免疫抑制剤による治療
CA3046093A1 (en) 2016-12-14 2018-06-21 Progenity Inc. Treatment of a disease of the gastrointestinal tract with an il-1 inhibitor
CN110430801B (zh) 2016-12-14 2024-04-30 比奥拉治疗股份有限公司 使用tnf抑制剂治疗胃肠道疾病
US20200253506A1 (en) 2016-12-14 2020-08-13 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an integrin inhibitor
WO2018112235A1 (en) 2016-12-14 2018-06-21 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a smad7 inhibitor
WO2018112237A1 (en) 2016-12-14 2018-06-21 Progenity Inc. Treatment of a disease of the gastrointestinal tract with an il-6r inhibitor
WO2018183941A2 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with live biotherapeutics
WO2018183932A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor
CA3054159A1 (en) 2017-03-30 2018-10-04 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a chst15 inhibitor
WO2018183929A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device
CA3054156A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
US20200306516A1 (en) 2017-08-14 2020-10-01 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with glatiramer or a pharmaceutically acceptable salt thereof
WO2019147824A1 (en) 2018-01-26 2019-08-01 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor
AU2019278927A1 (en) 2018-06-01 2020-12-24 Bt Bidco, Inc. Devices and systems for gastrointestinal microbiome detection and manipulation
WO2021207691A1 (en) 2020-04-10 2021-10-14 Rakuten Medical, Inc. Phthalocyanine dye compounds, conjugates and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927735A (en) * 1987-01-07 1990-05-22 Hitachi Chemical Company, Ltd. Novel naphthalocyanine dye, method for preparing the same, and optical information recording medium employing the same
ES2163393T3 (es) * 1990-05-15 2002-02-01 Hyperion Inc Porfirina fluorescente y ftalocianina fluorescente - derivados de polietilenglicol, poliol y sacaridos como sondas fluorescentes.
US5166197A (en) * 1990-07-17 1992-11-24 Kenney Malcolm E Phthalocyanine photosensitizers for photodynamic therapy
US5484778C1 (en) * 1990-07-17 2001-05-08 Univ Cleveland Hospitals Phthalocynine photosensitizers for photodynamic therapy and methods for their use
TW235298B (de) * 1992-02-27 1994-12-01 Ciba Geigy

Also Published As

Publication number Publication date
CA2267389A1 (en) 1998-04-09
EP1023399A4 (de) 2002-02-27
AU4662697A (en) 1998-04-24
WO1998014521A1 (en) 1998-04-09
EP1023399B1 (de) 2003-07-02
JP2001506584A (ja) 2001-05-22
EP1023399A1 (de) 2000-08-02
KR20000036186A (ko) 2000-06-26
DE69723322D1 (de) 2003-08-07
US5763602A (en) 1998-06-09
DE69723322T2 (de) 2004-05-27

Similar Documents

Publication Publication Date Title
ATE244279T1 (de) Verfahren zur synthese von phthalocyaninverbindungen
Brookhart et al. Enantioselective cyclopropane synthesis using the chiral carbene complexes (SFeSC)-and (RFeSC)-(C5H5)(CO)(Ph2R* P) Fe: CHCH3+ (R*=(S)-2-methylbutyl). Role of metal vs. ligand chirality in the optical induction
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
DE60005143D1 (de) Herstellung von iodixanol
DE69801764D1 (de) Verfahren zur herstellung von citalopram
DE69103265D1 (de) Verfahren zur stereoselektiven herstellung von phenylisoserinderivaten.
Moody et al. Stereospecific synthesis of 4-alkylglutamates and 4-alkylprolines
ATE264268T1 (de) Verfahren zur herstellung von zsm-5 und zsm-11
DE69207429D1 (de) Verfahren zur herstellung von substituierten piperidinen
ATE174601T1 (de) Verfahren zur herstellung von bisnoraldehyden aus bisnoralkohol
ATE160351T1 (de) Verfahren zur herstellung von 7-trialkylsilyl baccatin iii
ATE359272T1 (de) Verfahren zur herstellung von 3-hydroxy-n-1,6-
ATE270301T1 (de) Verfahren zur herstellung von modifizierten p- chiralen nucleotid-analoga
Nishide et al. One‐Step Stereocontrol of Three Contiguous Stereogenic Centers in Acyclic Systems: The Tuning Effect of an Additive in a Tandem Asymmetric Michael Addition and Meerwein–Ponndorf–Verley Reduction
ATE256108T1 (de) Verfahren zur herstellung von cholecalciferol- derivaten und zwischenverbindungen
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
RU2219161C2 (ru) Способ синтеза таксанов
Soucy et al. Remarkable diastereoselectivity in the addition of allylic and unsaturated diorganozinc reagents to β-(N, N-dialkylamino)-aldehydes
RU94046247A (ru) Способ получения практически беспыльного гранулята из тетрагидро-3,5-диметил-1,3,5-тиадиазин-2-тиона
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE59510633D1 (de) Verfahren zur herstellung von cyclischen lactamen
DE59502606D1 (de) Verfahren zur herstellung von selegilin
ATE159517T1 (de) Verfahren zur herstellung von n-carbonylarylimine als zwischenprodukte in der synthese von therapeutisch aktiven taxol-derivaten
DE60142962D1 (de) Verfahren zur herstellung von pestiziden verbindungen
Liu et al. A convenient synthesis of N-fluorenylmethoxycarbonyl-N-methyl-L-cysteine derivatives [Fmoc, Me-Cys (R)-OH]

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties